Investor
Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (TSXV: $KHRN.V) (TSXV:
$HVT.V) (CSE: $HBOR.C) (CSE:
$BHNG.C) (TSXV: $ELXR.V)
Delta, Kelowna, BC, December 4, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/12041KHRN-HVT-HBOR-BHNG-ELXR.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In today’s podcast
we look at a few early announcements.
But first, according to a recent study, Cannabis consumers are deeply concerned
with the use of chemical pesticides and fertilization and the environmental
impact resulting from the cultivation process, and are calling for new product
standards to ensure safety, freshness and efficacy, a new study in legalized
states shows.
Canivate
Growing Systems Ltd. (www.thecanivateway.com), conducted a U.S. nationwide survey of
more than 600 cannabis consumers in states where adult cannabis purchase is
legal. The survey found consumers overwhelmingly support establishing both
environmental standards (79% supporting) and quality certifications (77%) for
adult recreational cannabis products.
Respondents
indicated that they are willing to pay more for cannabis that is grown in an
eco-friendly, organic manner, with 64% of respondents agreeing. But when asked
about specific cultivation methods, that support increased dramatically.
Consumers strongly favor paying more for cannabis that is:
- grown
free from chemical pesticides (92%),
- without
chemical fertilizers (88%),
- hasn't
been irradiated for pathogens (85%),
- is
grown in a low carbon footprint environment (82.5%), and
- cultivated
in a manner that conserves water (86%).
"The research
suggests that consumers are more sophisticated and discerning in their brand
trust than was previously thought," said Troy McCellan, CEO of Canivate.
"We believe new approaches to cultivation and testing are needed to
preserve trust in this new market. The more educated consumers become, the more
they will demand products that are environmentally friendly and certifiably
proven to be free of chemical toxins, pathogens and decontamination
treatments."
Khiron
Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) welcomes today's announcement from ANVISA, the National Agency for Health
Surveillance of Brazil, establishing a legalized environment for the sale and
consumption of cannabis for medical use. The new regulations will be published
in the coming days on the Federal Official Gazette and enter into law 90 days
after that.
In the announcement
from ANVISA, a new class of medical cannabis-based products will be prescribed
by doctors and sold through pharmacies, enabling patient safe and legal access.
The regulatory framework sets a comprehensive procedure for the manufacture and
import of these products as well as the requirements for commercialization,
prescription, dispensing, monitoring and supervision of cannabis products for
medical purposes. The resolution was approved unanimously and is valid for an
initial three-year term.
Andres Galofre,
Khiron Co-founder and Vice President, Business Development, commented, "We
congratulate legislators and the health authority in Brazil for their
leadership in establishing a legalized environment for medical cannabis in the
country. With a population of over 200 million this will directly benefit the
health and wellbeing of a significant number of patients in Brazil and affirms
our position as a LatAm leader in a rapidly globalizing cannabis market."
Khiron has a firmly
established market-entry strategy for Brazil, with Dormul S.A., its wholly
owned subsidiary based in Uruguay giving the Company access to the Brazilian
market through the Mercosur Regional Trading Bloc. The Company has initiated
pre-clinical medical cannabis studies with the Universidad de la República of
Uruguay and Institut Pasteur de Montevideo, providing direct strategic
opportunity for 3 million patients for medical cannabis in Uruguay, and a
Brazilian market of 3.4 million (New Frontier Data). Further, on November 29th
the Company announced it had received authorization from the Colombian
Technical Quotas Group ("TQG") for the commercialization of medical
use High THC cannabis for domestic and export purposes, including to Brazil,
with manufacture to begin in Q1 2020.
Harvest
One Cannabis Inc. (TSX-V: HVT) (OTCQX: HRVOF) announced that its wholly-owned subsidiary and
Licensed Producer United Greeneries Ltd. has entered into an agreement with
Alberta Gaming, Liquor & Cannabis Commission to supply Captain's ChoiceTM
and Royal HighTM branded cannabis throughout the province.
"This
agreement with Alberta represents our fifth provincial supply agreement
providing another distribution channel for our premium cannabis products,"
said Grant Froese, Chief Executive Officer of Harvest One. "This is an
important partnership for Harvest One, as Alberta has the most robust
provincial retail network with over 330 store fronts and one of the largest
adult-use cannabis sales to date."
Under the terms of
the agreement, United Greeneries will initially launch five varieties of Royal
HighTM branded cannabis in whole-flower format as well as two
varieties of Captain's ChoiceTM branded pre-rolled product for sale
across Alberta in licensed cannabis stores. The Company is also working towards
listing new product categories such as oils, vapes and topicals, to be made
available for sale across the province.
United Greeneries
produces curated strains of cannabis at its facility located in Duncan, British
Columbia and through its cultivation agreement with Stevens Green in Ontario.
United Greeneries' cannabis is consistently regarded as a high quality and
sought-after product and is now available in five provinces; Ontario, British
Columbia, Alberta, Manitoba and Saskatchewan.
Alberta is home to
over 330 licensed cannabis stores fronts which represents the largest number of
retail outlets in any province in the country. Harvest One will continue to
seek new markets for both existing cannabis flower products as well as new
cannabis infused products where regulations allow.
Harborside
Inc. (CSE: HBOR), a California-focused,
vertically-integrated cannabis enterprise, today announced the Grand Opening of their newest
dispensary in Desert Hot Springs, this Saturday. The store is Harborside's
first retail location outside of the Bay Area and will also be the first
drive-thru dispensary in Southern California. Harborside co-founder Steve
DeAngelo, local elected officials and other surprise celebrity guests will
officially open the dispensary and drive-thru at a public celebration this
Saturday.
The 4,800 square
foot facility is strategically located on Interstate 10 between Los Angeles and
Coachella and will carry both medical and adult-use products, including
Harborside's own KEY line of cannabis products. In addition to its highly
anticipated drive-thru, the Desert Hot Springs location will partner with Pure
Healing Clinic, offering professional acupuncture, herbal medicine and other
wellness services. This latest expansion marks Harborside's fourth retail
operation in California.
"Harborside is
committed to bringing exceptional cannabis products to our neighboring
communities, and is proud to provide the Southern California market with
best-in-class service and convenience," said Peter Bilodeau, interim CEO
of Harborside. "We are especially pleased to have obtained one of the few
drive-thru dispensary licenses in Southern California."
"Harborside
decided to come to the Coachella Valley because we like to be where the action
is," said co-founder and Chairman Emeritus Steve DeAngelo. "The Valley
is growing into a world-class center of both the cannabis industry and cannabis
tourism, so it's an ideal location to introduce the legendary Harborside retail
model and in-house brands to a wider population. We're also bringing some
things that the Valley hasn't seen yet, like our drive-thru, an on-site
holistic healing clinic, and the legendary knowledge and compassion of our
associates."
Bhang
Inc. (CSE: BHNG) (OTCQX: BHNGF), a global cannabis CPG brand company with
an extensive, award-winning portfolio of products, announced today that Jamie L. Pearson, Bhang’s Interim
President, will assume the role of President & CEO, overseeing day-to-day
management and strategic initiatives. Scott Van Rixel has stepped down as CEO.
“I am pleased to
announce Jamie’s promotion to both President & CEO of Bhang. Jamie has
shown considerable strength in her role as President and her work to develop a
vision for Bhang’s future. I am confident that Jamie has the necessary skills
to lead Bhang and execute our business objectives,” said Scott Van Rixel.
Bhang has issued a
letter to its shareholders from Ms. Pearson, providing commentary on the
Company's recent developments and upcoming objectives.
The Company is also
proud to announce that Jamie was selected as one of the 2019 High Times Female
Top 50. The award honors the 50 most influential women across the cannabis
landscape, from activists, executives, and scientists, patients, and
politicians. The honorees were selected by the brand’s editorial leadership
from a pool of over 7,500 public nominations. High Times further honored Jamie
by asking her to give the keynote address entitled ‘Breaking the Glass Ceiling’
to the honorees and approximately 300 people on November 13 at the Beverly
Wilshire Hotel in California. A copy of her speech can be found on Bhang’s
website HERE along with a copy of the full letter
below.
Below
are some of the highlights from Pearson’s letter to the shareholders.
“Over
the past decade, Bhang has become one of the most-recognized brands in cannabis
and central to our thesis is our low CAPEX/OPEX operating platform. We do not
need to own multi-million-dollar greenhouses, massive production facilities or
extravagant retail operations. Our capital-light business model has enabled us
to be quick and nimble and is clearly a differentiator. Bhang’s focus is on
being a great CPG company – period. We offer excellent products that consumers
want and use top-tier manufacturing and distribution partners to get these
products into consumers’ hands.”
“Our
approach going forward will be to focus on reducing expenses and increasing
revenues across product verticals that fall into our food/beverage, lifestyle,
and wellness categories. I am pleased to provide the following update on
existing and upcoming Bhang initiatives:”
Pearson
also went on to discuss the company’s CBD Domestic & Global Distribution,
CBD Brokerage, E-Commerce, Red Ace Organics and their THC Licensing Revenue
Streams and Deep Manufacturing/Distribution Relationships in Nevada, Florida,
Ohio, Michigan, Illinois and Canada.
Elixxer
Ltd. (TSX-V: ELXR) (OTCQB: ELXIF) announced that Global Canna Labs has successfully
exported 10 kilograms of medical cannabis from Jamaica into Canada.
This shipment of
medical cannabis, the largest of its kind known to date, is a significant step
forward in the development of Jamaica’s medical, therapeutic and scientific
cannabis industry. The Caribbean
Licensing Authority, CLA, has been working diligently on creating a viable
export platform. Jamaica’s Minister of
Industry, Commerce, Agriculture and Fisheries, the Honorable Audley Shaw
applauded the news as he recently presented at the CanEx Investment Summit in
Toronto on November 28th.
For further
information please refer to: Jamaican Observer, December 4th, 2019:
Investor ideas
reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com Global investors
must adhere to regulations of each country. Please read Investorideas.com
privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
